Skip to content
Subscribe

Do You Believe Trump’s Promise to Lower Drug Prices? This Nonpartisan Prophet Does…

Do You Believe Trump’s Promise to Lower Drug Prices? This Nonpartisan Prophet Does…
Published:

President Trump rarely received a standing ovation from the entirety of the audience at his first State of the Union address. One of the rare moments came when he spoke about knocking down America’s outrageous drug prices.

“One of my greatest priorities is to reduce the price of prescription drugs. In many other countries, these drugs cost far less than what we pay in the United States. That is why I have directed my administration to make fixing the injustice of high drug prices one of our top priorities. Prices will come down.”

Many are skeptical of his declaration, especially since he mentioned combatting high drug prices during his campaign and no action took place in 2017.

There’s some hope this time will be different. Not only did President Trump mention drug prices in his State of the Union, but just one day prior, President Trump put in place a new Health and Human Services Secretary (Alex Azar) and charged him with finding a solution to bringing prescription prices down. At the swearing in Trump stated, “He’s going to get those prescription drug prices way down.”

Should you believe 2018 President Trump? Well, one of our most nonpartisan barometers of future action seems to believe him.

Upon market-close the day after the State of the Union, pharmaceutical stocks were smashed.

Some of the larger producers of medical drugs were hit hard:

Merck & Co. (ticker: MRK) lost 2.31% or about $3.8 billion off its market cap.Amgen Inc. (ticker: AMGN), dropped 2.73% or about $3.8 billion.AbbVie Inc. (ticker: ABBV), fell 3.16% or about A$5.8 billion.Mylan NV (ticker: MYL) lost 2.66% or about $644 million.Gilead Sciences Inc. (ticker: GILD) sunk 4% or about $4.6 billion.Bristol-Myers Squibb Co. (ticker: BMY) was hit for 2.13% or about $2.2 billion.The total market cap lost by the companies above comes out to $20.8 billion. That’s a lot of money that fled pharmaceuticals, and there’s nothing partisan about the decisions behind making or losing money in the markets. The markets are betting President Trump’s words turn into actions.

Now we just have to wait and see if the markets bet correctly.

© 2018 Free Wheel Media. The article originally published on FreeWheelUs, and was republished with permission and by request of Free Wheel Media.

Adhere to the IVN etiquette

By posting a comment, you agree to adhere to our etiquette rules: No partisan attacks, no personal attacks, substantiate your sources, no self-promotion.

Contact IVN

Questions about this article or our coverage? Send us a message. A free IVN member account is required.

Message sent

Thanks, we’ll review it and get back to you if needed.

Message not sent

Sorry, something went wrong. Please try again.

Sign in to send a message

Messages are tied to your IVN member account. Signing in is free and takes a few seconds.

Contact IVN

Questions about this article or our coverage? Send us a message. A free IVN member account is required.

Message sent

Thanks, we’ll review it and get back to you if needed.

Message not sent

Sorry, something went wrong. Please try again.

Sign in to send a message

Messages are tied to your IVN member account. Signing in is free and takes a few seconds.

Republish this article

Republishing guidelines

Republish IVN articles for free. Independent Voter News articles may be republished online or in print under a Creative Commons BY-NC-ND 4.0 license, on these terms:

  1. Credit the author and IVN. Keep the byline ("By Author Name, Independent Voter News") and the attribution note at the end, which links to the original.
  2. Keep the meaning. You may update time and place references and apply your house style. You may trim for length, as long as the cuts don't change the meaning or misrepresent the author. Keep the headline. Mark any additions as your own (for example "Additional reporting by ...").
  3. Translations are welcome. Translate faithfully, add "Translated from English by [your outlet]", and tell us at editor@ivn.us.
  4. Keep the links, including the link to the original article.
  5. Keep the tracking image. The HTML includes a 1-pixel image that counts readers on your page. It collects no personal information.
  6. Photos and illustrations. Images credited to IVN may be used with this article only. Images credited to others (AP, Getty, Unsplash, Wikimedia and so on) stay under their owners' terms. Secure the rights or switch "Include images" off.
  7. Don't sell it. You can't sell our articles or sell ads specifically against them. Your normal site advertising is fine.
  8. No implied endorsement. Don't suggest that IVN or the author endorses you, your candidates or your causes, or that donations to you support IVN.
  9. Keep labels. Opinion or analysis pieces keep that label.
  10. Point search engines to the original. Where your CMS allows, set the canonical URL to the original IVN article.
  11. No bulk or automated republishing, and don't submit our articles to aggregators (Apple News, Google News, MSN) as your own.
  12. Corrections and removals. Update your copy when we correct it, and remove it promptly if we ask. We'll contact you at the email you give us.
  13. Questions or print republication: editor@ivn.us.

IVN staff: fill in who you're inviting above, then create the invite.

Preparing the article

Do You Believe Trump’s Promise to Lower Drug Prices? This Nonpartisan Prophet Does…

Choose a format
  • HTML
  • Email HTML
  • Markdown
  • Formatted (.docx)
  • Plain text
  • WordPress blocks
  • PDF
Choose a platform

Photos credited to others need their owners' permission.

To for

Republishing somewhere else? Questions? editor@ivn.us